Search - tctmd.com

Displaying 141 - 160 of 349

Sort: Relevancy | Date

News Daily News

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Michael O'Riordan

July 19, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Todd Neale

July 04, 2019

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

News Daily News

Tool May Ease Use of High-Sensitivity Troponin for Acute MI Diagnosis

Todd Neale

June 28, 2019

News Conference News EAS 2019

FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis

Michael O'Riordan

June 03, 2019

News Conference News EuroPCR 2019

Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS

Michael O'Riordan

May 21, 2019

News Daily News

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

Michael O'Riordan

April 18, 2019

News Daily News

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

Michael O'Riordan

April 11, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Daily News

AHA Statement on MINOCA Provides a Standard Definition, Clinical Care Algorithms

Yael L. Maxwell

April 03, 2019

News Conference News ACC 2019

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

L.A. McKeown

March 27, 2019

News Daily News

‘Striking’ Improvements in Acute MI Care Over Past 20 Years, Report Shows

Michael O'Riordan

March 19, 2019

News Daily News

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

L.A. McKeown

January 08, 2019

News Daily News

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

Caitlin E. Cox

November 28, 2018

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News AHA 2018

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Shelley Wood

November 11, 2018

Advertisement

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Tool May Ease Use of High-Sensitivity Troponin for Acute MI Diagnosis

FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis

Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

AHA Statement on MINOCA Provides a Standard Definition, Clinical Care Algorithms

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

‘Striking’ Improvements in Acute MI Care Over Past 20 Years, Report Shows

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content